[Does the asymptomatic carriage of FV Leiden and FII prothrombin in heterozygous configuration represent the increased risk of thrombembolic complications during pregnancy, childbirth and postpartum?].

Abstract excerpt

OBJECTIVE: To evaluate the course of pregnancy and puerperium in asymptomatic carriers of FV Leiden and FII prothrombin mutation in heterozygous configuration in terms of risk of thrombembolic disease and late pregnancy complications. To evaluate whether global prophylactic LMWH administration al...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticoagulants
• Share to Asymptomatic Diseases
• Share to Blood Coagulation Tests